Dr. Nazha is the director of the Cleveland Clinic Center for Clinical Artificial Intelligence and an Associate Medical Director at Enterprise Analytics. He is also an Assistant Professor of Medicine at Lerner College of Medicine/Case Western Reserve University and an Associate Staff at the Department of Hematology and Medical Oncology at Taussig Cancer Institute, Cleveland Clinic.
Dr. Nazha completed his Hematology and Medical Oncology fellowship at Cleveland Clinic and a Leukemia Fellowship at The University of Texas MD Anderson Cancer Center where he also served as an instructor in the Leukemia Department.
Dr. Nazha is nationally and internationally recognized expert in treating patients with leukemia. His research focuses on using artificial intelligence, machine learning, and deep learning to translate genomic and complex healthcare data into useful clinical tools that can improve patient outcomes. He is also a programmer and has developed multiple machine learning and deep learning models to improve the diagnosis, prognosis, and treatment options for patients with leukemia. He serves as a member of the NCCN guidelines for myelodysplastic syndromes. He is also a member of the International Working Group of MDS/MPN (IWG MDS/MPN), the International Working Group of myelodysplastic syndromes (IWG MDS) and a member in the acute and chronic leukemia committees at the Center for International Blood and Marrow Transplant Research. He is the recipient of several prestigious research awards including the NIH K12 Career Development Award, Future Leader in Hematology for Clinical Research Award, the James S. and Suzanne Cyrus Scholar Award Finalist, William E. Lower Non-Clinical Research Award, Peskind Memorial Award for Excellence in Scientific Research, and the Next Generation Innovator Award among many other teaching and service awards. He is also named in the list of 30 under 40 Leaders who are Transforming Healthcare by Business Insider.
Dr. Nazha has published more than 80 peer-reviewed manuscripts, review articles, and book chapters. He is on the editorial board of Journal of Clinical Oncology Clinical Informatics, Annals of Hematology & Oncology, Cancer Biology & Medicine, and Cancer Treatment and Research Communications. He is also an ad hoc reviewer for Journal of Clinical Oncology (JCO), JAMA Oncology, Leukemia, British Journal of Hematology, The Oncologist, and many others.
Dr. Nazha is a member of the American Society of Hematology, American Society of Clinical Oncology, American Association of Cancer Research, and the American Society of Physicians.